CardioMag to sell MCG in the U.S. following FDA approval
CardioMag Imaging Inc. of Schenectady, N.Y., has received clearance from the FDA to market and sell the magnetocardiograph (MCG), a cardiac device which can detect the magnetic field generated by a person's heart.

According to CardioMag, six hospitals are already using the device to study, for instance, the ability of MCG to detect coronary artery disease. One of the institutes, Cedars-Sinai Medical Center in Los Angeles, Calif., is conducting research with the device in its non-invasive cardiology lab.

An MCG procedure takes less than 10 minutes to perform, does not require injections or radiation and generates a thousand images per heartbeat, said CardioMag.

Devices are currently installed in the Europe and Asia.